Synergistic Bcl-2 inhibition by ABT-737 and cyclosporine A

Apoptosis

Volumn 18, Issue 3, 2013, Pages 315-323

  Cippà, Pietro E ^a,b   Kamarashev, Jivko ^c   Chen, Jin ^a,b   Kraus, Anna K ^a,b   Segerer, Stephan ^a,b   Feldmeyer, Laurence ^c   Fehr, Thomas ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

ABT 737; Bcl 2; Calcineurin; Cyclosporine A; Lymphocyte; Melanocyte

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; CYCLOSPORIN A; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DEPIGMENTATION; DRUG POTENTIATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MELANOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; SPLEEN CELL;

ANIMALS; APOPTOSIS; BIPHENYL COMPOUNDS; CALCINEURIN; CYCLOSPORINE; DRUG SYNERGISM; HAIR COLOR; LYMPHOCYTES; MELANOCYTES; MICE; NITROPHENOLS; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-BCL-2; SULFONAMIDES;

MUS;

EID: 84877121670     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-012-0778-2     Document Type: Article

References (37)

1. Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9:47-59
2. Verma YK, Gangenahalli GU, Singh VK et al (2006) Cell death regulation by B-cell lymphoma protein. Apoptosis 11:459-471
3. Vaux DL, Cory S, Adams JM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442
4. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ (1993) Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-240
5. Oltersdorf T, Elmore SW, Shoemaker AR et al (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435:677-681
6. Tse C, Shoemaker AR, Adickes J et al (2008) ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res 68:3421-3428
7. Konopleva M, Contractor R, Tsao T et al (2006) Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell 10:375-388
8. Vogler M, Dinsdale D, Dyer MJ, Cohen GM (2009) Bcl-2 inhibitors: small molecules with a big impact on cancer therapy. Cell Death Differ 16:360-367
9. Wilson WH, O'Connor OA, Czuczman MS et al (2010) Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol 11:1149-1159
10. Bardwell PD, Gu J, McCarthy D et al (2009) The Bcl-2 family antagonist ABT-737 significantly inhibits multiple animal models of autoimmunity. J Immunol 182:7482-7489
11. Lawlor KE, Smith SD, van Nieuwenhuijze A, Huang DC, Wicks IP (2011) Evaluation of the Bcl-2 family antagonist ABT-737 in collagen-induced arthritis. J Leukoc Biol 90:819-829
12. Carrington EM, Vikstrom IB, Light A et al (2010) BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs. Proc Natl Acad Sci USA 107:10967-10971
13. Cippa PE, Kraus AK, Edenhofer I et al (2011) The BH3-mimetic ABT-737 inhibits allogeneic immune responses. Transpl Int 24:722-732
14. Wojciechowski S, Tripathi P, Bourdeau T et al (2007) Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J Exp Med 204:1665-1675
15. Marsden VS, Strasser A (2003) Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol 21:71-105
16. Cippa PE, Kraus AK, Lindenmeyer MT et al (2012) Resistance to ABT-737 in activated T lymphocytes: molecular mechanisms and reversibility by inhibition of the calcineurin-NFAT pathway. Cell Death Dis 3:e299
17. Manicassamy S, Gupta S, Huang Z, Molkentin JD, Shang W, Sun Z (2008) Requirement of calcineurin a beta for the survival of naive T cells. J Immunol 180:106-112
18. Ying S, Khan LN, Meng Q, Barnes NC, Kay AB (2003) Cyclosporin A, apoptosis of BAL T-cells and expression of Bcl-2 in asthmatics. Eur Respir J 22:207-212
19. Bouillet P, Metcalf D, Huang DC et al (1999) Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286:1735-1738
20. Segerer S, Hudkins KL, Taneda S et al (2002) Oral interferon-alpha treatment of mice with cryoglobulinemic glomerulonephritis. Am J Kidney Dis 39:876-888
21. Robinson KC, Fisher DE (2009) Specification and loss of melanocyte stem cells. Semin Cell Dev Biol 20:111-116
22. Bouillet P, Cory S, Zhang LC, Strasser A, Adams JM (2001) Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev Cell 1:645-653
23. Shibasaki F, Kondo E, Akagi T, McKeon F (1997) Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature 386:728-731
24. Shibasaki F, Hallin U, Uchino H (2002) Calcineurin as a multifunctional regulator. J Biochem 131:1-15
25. Haldar S, Jena N, Croce CM (1995) Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci U S A 92:4507-4511
26. Wang HG, Pathan N, Ethell IM et al (1999) Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284:339-343
27. Srivastava RK, Sasaki CY, Hardwick JM, Longo DL (1999) Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription. J Exp Med 190:253-265
28. Verschelde C, Walzer T, Galia P et al (2003) A1/Bfl-1 expression is restricted to TCR engagement in T lymphocytes. Cell Death Differ 10:1059-1067
29. Zamzami N, Marchetti P, Castedo M et al (1996) Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett 384:53-57
30. Eliseev RA, Malecki J, Lester T, Zhang Y, Humphrey J, Gunter TE (2009) Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect. J Biol Chem 284:9692-9699
31. Vogler M, Hamali HA, Sun XM et al (2011) BCL2/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation. Blood 117:7145-7154
32. Sahin G, Akay OM, Bal C, Yalcin AU, Gulbas Z (2011) The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients. Clin Nephrol 76:218-225
33. Nishimura EK, Granter SR, Fisher DE (2005) Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science 307:720-724
34. Keuling AM, Felton KE, Parker AA, Akbari M, Andrew SE, Tron VA (2009) RNA silencing of Mcl-1 enhances ABT-737-mediated apoptosis in melanoma: role for a caspase-8-dependent pathway. PLoS ONE 4:e6651
35. Sorenson CM, Padanilam BJ, Hammerman MR (1996) Abnormal postpartum renal development and cystogenesis in the bcl-2 (-/-) mouse. Am J Physiol 271:F184-F193
36. Ziehr J, Sheibani N, Sorenson CM (2004) Alterations in cell-adhesive and migratory properties of proximal tubule and collecting duct cells from bcl-2 -/- mice. Am J Physiol Renal Physiol 287:F1154-F1163
37. Nagata M, Nakauchi H, Nakayama K, Nakayama K, Loh D, Watanabe T (1996) Apoptosis during an early stage of nephrogenesis induces renal hypoplasia in bcl-2-deficient mice. Am J Pathol 148:1601-1611